Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ningkun Jieyu Decoction for perimenopausal anxiety disorder
ChiCTR2400080171Phase 2Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Ningkun Jieyu Decoction, estradiol, flupentixol and melitracen in anxiety disorder (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoints: Estradiol, Follicle-stimulating hormone and 8 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
Ningkun Jieyu Decoctionestradiolflupentixolmelitracen
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2400080171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080171.